Spots Global Cancer Trial Database for her2 enriched subtype breast cancer, herzuma, pam50 study
Every month we try and update this database with for her2 enriched subtype breast cancer, herzuma, pam50 study cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study) | NCT04817540 | HER2 Enriched S... | Herzuma | 19 Years - | Gangnam Severance Hospital | |
| Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study) | NCT04817540 | HER2 Enriched S... | Herzuma | 19 Years - | Gangnam Severance Hospital | |
| Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study) | NCT04817540 | HER2 Enriched S... | Herzuma | 19 Years - | Gangnam Severance Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
